Literature DB >> 31609927

Use of an Indeterminate Range in HIV Early Infant Diagnosis: A Systematic Review and Meta-Analysis.

Robert Luo1, Debi Boeras1, Laura N Broyles1, Youyi Fong2, Nei-Yuan Hsiao3, Charles Kiyaga4, Ahmad Haeri Mazanderani5, Landon Myer3, Roger Shapiro6, Gayle Sherman5, Martina Penazzato7, Meg Doherty7, Lara Vojnov7.   

Abstract

BACKGROUND: Expanded access to HIV antiretrovirals has dramatically reduced mother-to-child transmission of HIV. However, there is increasing concern around false-positive HIV test results in perinatally HIV-exposed infants but few insights into the use of indeterminate range to improve infant HIV diagnosis.
METHODS: A systematic review and meta-analysis was conducted to evaluate the use of an indeterminate range for HIV early infant diagnosis. Published and unpublished studies from 2000 to 2018 were included. Study quality was evaluated using GRADE and QUADAS-2 criteria. A random-effects model compared various indeterminate ranges for identifying true and false positives.
RESULTS: The review identified 32 studies with data from over 1.3 million infants across 14 countries published from 2000 to 2018. Indeterminate results accounted for 16.5% of initial non-negative test results, and 76% of indeterminate results were negative on repeat testing. Most results were from Roche tests. In the random-effects model, an indeterminate range using a polymerase chain reaction cycle threshold value of ≥33 captured over 93% of false positives while classifying fewer than 9% of true positives as indeterminate.
CONCLUSIONS: Without the use of an indeterminate range, over 10% of infants could be incorrectly diagnosed as HIV positive if their initial test results are not confirmed. Use of an indeterminate range appears to lead to substantial improvements in the accuracy of early infant diagnosis testing and supports current recommendations to confirm all initial positive tests.

Entities:  

Mesh:

Year:  2019        PMID: 31609927     DOI: 10.1097/QAI.0000000000002104

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  4 in total

1.  Assessing the Variability of Cell-Associated HIV DNA Quantification through a Multicenter Collaborative Study.

Authors:  Yann Le Duff; Kathleen Gärtner; Eloise J Busby; Annalisa Dalzini; Sivapragashini Danaviah; José Luis Jiménez Fuentes; Carlo Giaquinto; Jim F Huggett; Matthew Hurley; Anne-Geneviève Marcellin; María Ángeles Muñoz-Fernández; Denise M O'Sullivan; Deborah Persaud; Laura Powell; Peter Rigsby; Paolo Rossi; Anita de Rossi; Lilly Siems; Theresa Smit; Sarah A Watters; Neil Almond; Eleni Nastouli
Journal:  Microbiol Spectr       Date:  2022-06-06

2.  Implementing an Indeterminate Range for More Accurate Early Infant Diagnosis.

Authors:  Lara Vojnov; Martina Penazzato; Gayle Sherman; Anisa Ghadrshenas; Elaine J Abrams; Meg Doherty
Journal:  J Acquir Immune Defic Syndr       Date:  2019-11-01       Impact factor: 3.731

3.  Delays in HIV-1 infant polymerase chain reaction testing may leave children without confirmed diagnoses in the Western Cape province, South Africa.

Authors:  Kamela L Mahlakwane; Wolfgang Preiser; Nokwazi Nkosi; Nasheen Naidoo; Gert van Zyl
Journal:  Afr J Lab Med       Date:  2022-06-23

4.  Loss to follow-up of HIV-exposed infants for confirmatory HIV test under Early Infant Diagnosis program in India: analysis of national-level data from reference laboratories.

Authors:  Nilesh Gawde; Suchit Kamble; Noopur Goel; Kalyani Nikhare; Shilpa Bembalkar; Mohan Thorwat; Dhanashree Jagtap; Swarali Kurle; Neeru Yadav; Vinita Verma; Neha Kapoor; Chinmoyee Das
Journal:  BMC Pediatr       Date:  2022-10-18       Impact factor: 2.567

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.